nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absolute Oral Bioavailability and Disposition of Deferasirox in Healthy Human Subjects
|
Séchaud, Romain |
|
2008 |
|
8 |
p. 919-925 |
artikel |
2 |
A Comparative Multidose Pharmacokinetic Study of Buspirone Extended-Release Tablets with a Reference Immediate-Release Product
|
Sakr, Adel |
|
2001 |
|
8 |
p. 886-894 |
artikel |
3 |
A Controlled Comparative Study of Ibuprofen Arginate versus Conventional Ibuprofen in the Treatment of Postoperative Dental Pain
|
Mehlisch, Donald R. |
|
2002 |
|
8 |
p. 904-911 |
artikel |
4 |
Acyclovir Bioavailability in Patients With Acute Myelogenous Leukemia Treated With Daunorubicin and Cytarabine
|
Sitar, Daniel S. |
|
2008 |
|
8 |
p. 995-998 |
artikel |
5 |
A Double-Blind, Placebo-Controlled, Dose-Response Study of the Effectiveness and Safety of Enalapril for Children with Hypertension
|
Wells, Thomas |
|
2002 |
|
8 |
p. 870-880 |
artikel |
6 |
Adverse Drug Reactions and Avalanches: Life at the Edge of Chaos
|
Frattarelli, Daniel A.C. |
|
2005 |
|
8 |
p. 866-871 |
artikel |
7 |
A Lesson in Moderation: Applying Pharmacodynamics to Clarify the Relationship Between Thiazolidinediones and Adverse Vascular Outcomes in Type 2 Diabetes
|
Lehmann, David F. |
|
2008 |
|
8 |
p. 999-1002 |
artikel |
8 |
A Limited Sampling Method for the Estimation of Serum Calcitriol Area Under the Curve in Cancer Patients
|
Muindi, Josephia R. |
|
2003 |
|
8 |
p. 894-900 |
artikel |
9 |
American College of Clinical Pharmacology
|
|
|
2004 |
|
8 |
p. 941-1-941-2 |
artikel |
10 |
A Model for Glucose, Insulin, and Beta-Cell Dynamics in Subjects With Insulin Resistance and Patients With Type 2 Diabetes
|
Ribbing, Jakob |
|
2010 |
|
8 |
p. 861-872 |
artikel |
11 |
A Multiphasic Absorption Model Best Characterizes Gastrointestinal Absorption of Divalproex Sodium Extended-Release Tablets
|
Dutta, Sandeep |
|
2006 |
|
8 |
p. 952-957 |
artikel |
12 |
Analysis of Factors Influencing Tacrolimus Levels and Immunoassay Bias in Renal Transplantation
|
Borrows, Richard |
|
2007 |
|
8 |
p. 1035-1042 |
artikel |
13 |
An Introduction to Clinical Research and Drug Development for Pharmacy and Pharmacology Graduate Students
|
Smith, Judith A. |
|
2002 |
|
8 |
p. 867-869 |
artikel |
14 |
A Phase I Multiple-Dose Escalation Study Characterizing Pharmacokinetics and Safety of ABT-578 in Healthy Subjects
|
Karyekar, Chetan S. |
|
2005 |
|
8 |
p. 910-918 |
artikel |
15 |
Argatroban Anticoagulation in Obese Versus Nonobese Patients: Implications for Treating Heparin-induced Thrombocytopenia
|
Rice, Lawrence |
|
2007 |
|
8 |
p. 1028-1034 |
artikel |
16 |
Assessment of the Effects of Renal Impairment on the Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat After a Single Intravenous Dose
|
Lettieri, John T. |
|
2012 |
|
8 |
p. 1240-1247 |
artikel |
17 |
A Study of Organic Acid Transporter—Mediated Pharmacokinetic Interaction Between NXY-059 and Cefuroxime
|
KÅgedal, Matts |
|
2007 |
|
8 |
p. 1043-1048 |
artikel |
18 |
A Thorough Electrocardiogram Study of Edoxaban, a Novel Factor Xa Inhibitor
|
Mendell, J. |
|
2011 |
|
8 |
p. 1241-1246 |
artikel |
19 |
A Thorough QTc Study to Assess the Effect of Sitagliptin, a DPP4 Inhibitor, on Ventricular Repolarization in Healthy Subjects
|
Bloomfield, Daniel M. |
|
2009 |
|
8 |
p. 937-946 |
artikel |
20 |
Atorvastatin Treatment and Vaccination Efficacy
|
Packard, René R. S. |
|
2007 |
|
8 |
p. 1022-1027 |
artikel |
21 |
Author’s Response
|
Wang, Diane D. |
|
2012 |
|
8 |
p. 1286-1287 |
artikel |
22 |
Beneficial Effect of Vardenafil on Aortic Stiffness and Wave Reflections
|
Vlachopoulos, Charalambos |
|
2012 |
|
8 |
p. 1215-1221 |
artikel |
23 |
Beneficial Impact of Xuezhikang on Cardiovascular Events and Mortality in Elderly Hypertensive Patients With Previous Myocardial Infarction From the China Coronary Secondary Prevention Study (CCSPS)
|
Li, Jian-Jun |
|
2009 |
|
8 |
p. 947-956 |
artikel |
24 |
BookReview: Mahmood I, ed. Clinical Pharmacology of Therapeutic Proteins. Rockville, MD: Pine House; 2006; 565 pp, hardcover, $180.00. Meibohm B, ed. Pharmacokinetics and Pharmacodynamics of Biotech Drugs: Principles and Case Studies in Drug Development. Weinheim, Germany: Wiley-VCH Verlag GmBH &CO, KGaA; 2007; 403 pp, hardcover, $175.00
|
|
|
2007 |
|
8 |
p. 1058-1059 |
artikel |
25 |
BookReview: Matthews DE, Farewell VT. Using and Understanding Medical Statistics. 4th ed. Basel, Switzerland: Karger; 2007; 322 pp, 42 figures, 113 tables, hardcover, $44.00
|
|
|
2007 |
|
8 |
p. 1059-1060 |
artikel |
26 |
BookReview: Rose K, van den Anker JN, eds. Guide to Paediatric Clinical Research, Basel, Switzerland: Karger; 2007; 138 pp, 8 figures, 8 tables, hardcover, $83.75
|
|
|
2007 |
|
8 |
p. 1059-1059 |
artikel |
27 |
Central Effects of Fexofenadine and Cetirizine: Measurement of Psychomotor Performance, Subjective Sleepiness, and Brain Histamine H1-Receptor Occupancy Using 11C-Doxepin Positron Emission Tomography
|
Tashiro, Manabu |
|
2004 |
|
8 |
p. 890-900 |
artikel |
28 |
Characterization of the Human QT Interval: Novel Distribution-Based Assessment of the Repolarization Effects of Moxifloxacin
|
Holzgrefe, Henry H. |
|
2012 |
|
8 |
p. 1222-1239 |
artikel |
29 |
Chronopharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Occurrence of Acute Rejection
|
Tada, Hitoshi |
|
2003 |
|
8 |
p. 859-865 |
artikel |
30 |
Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers
|
Bockbrader, Howard N. |
|
2010 |
|
8 |
p. 941-950 |
artikel |
31 |
Clinical Pharmacology of Rasagiline: A Novel, Second-Generation Propargylamine for the Treatment of Parkinson Disease
|
Chen, Jack J. |
|
2005 |
|
8 |
p. 878-894 |
artikel |
32 |
Cocktail Approach for In Vivo Phenotyping of 5 Major CYP450 Isoenzymes: Development of an Effective Sampling, Extraction, and Analytical Procedure and Pilot Study With Comparative Genotyping
|
Wohlfarth, Ariane |
|
2012 |
|
8 |
p. 1200-1214 |
artikel |
33 |
Comparative Effects of Atorvastatin, Simvastatin, and Fenofibrate on Serum Homocysteine Levels in Patients with Primary Hyperlipidemia
|
Milionis, Haralampos J. |
|
2003 |
|
8 |
p. 825-830 |
artikel |
34 |
Comparison of Azathioprine and Mycophenolate Mofetil for the Prevention of Acute Rejection in Recipients of Pancreas Transplantation
|
Oh, Jung M. |
|
2001 |
|
8 |
p. 861-869 |
artikel |
35 |
Comparison of Semiautomated and Fully Automated Methods for QT Measurement During a Thorough QT/QTc Study: Variability and Sample Size Considerations
|
Tyl, Benoît |
|
2009 |
|
8 |
p. 905-915 |
artikel |
36 |
Comparison of the Gastrointestinal Absorption and Bioavailability of Fenofibrate and Fenofibric Acid in Humans
|
Tong Zhu, |
|
2010 |
|
8 |
p. 914-921 |
artikel |
37 |
Comparison of the Pharmacokinetics of 17β-Estradiol after a Single 4-Day Application of Oesclim® 50, Oesclim® 100, and Vivelle® 0.05 (Menorest® 50) Transdermal Delivery Systems
|
Guichard, Jean-Pierre |
|
1999 |
|
8 |
p. 811-816 |
artikel |
38 |
Concomitant Cyclosporine and Micafungin Pharmacokinetics in Healthy Volunteers
|
Hebert, Mary F. |
|
2005 |
|
8 |
p. 954-960 |
artikel |
39 |
Contributions of Five Human Cytochrome P450 Isoforms to the N-demethylation of Clozapine In Vitro at Low and High Concentrations
|
Olesen, Ole V. |
|
2001 |
|
8 |
p. 823-832 |
artikel |
40 |
Conversion From Subcutaneous to Intravenous Erythropoietin in a Hemodialysis Population
|
Vercaigne, Lavern M. |
|
2005 |
|
8 |
p. 895-900 |
artikel |
41 |
Correlation of Inhibition of Platelet Aggregation With Cardiovascular and Bleeding Outcomes in Acute Coronary Syndromes
|
Wada, Russ |
|
2010 |
|
8 |
p. 904-913 |
artikel |
42 |
Daily Honey Consumption Does Not Change CYP3A Activity in Humans
|
Fetzner, Leonie |
|
2011 |
|
8 |
p. 1223-1232 |
artikel |
43 |
Delay of Ovulation by Meloxicam in Healthy Cycling Volunteers: A Placebo-Controlled, Double-blind, Crossover Study
|
Bata, M. S. |
|
2006 |
|
8 |
p. 925-932 |
artikel |
44 |
Dental Impaction Pain Model as a Potential Tool to Evaluate Drugs With Efficacy in Neuropathic Pain
|
Malmstrom, Kerstin |
|
2006 |
|
8 |
p. 917-924 |
artikel |
45 |
Direct-to-Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology
|
Ameer, Barbara |
|
2009 |
|
8 |
p. 886-888 |
artikel |
46 |
Dosing Celecoxib in Pediatric Patients With Juvenile Rheumatoid Arthritis
|
Krishnaswami, Sriram |
|
2012 |
|
8 |
p. 1134-1149 |
artikel |
47 |
Drug Utilization Pattern in the Intensive Care Unit of a Tertiary Care Hospital
|
Biswal, S. |
|
2006 |
|
8 |
p. 945-951 |
artikel |
48 |
Effect of Drospirenone on Serum Potassium and Drospirenone Pharmacokinetics in Women With Normal or Impaired Renal Function
|
Schürmann, Rolf |
|
2006 |
|
8 |
p. 867-875 |
artikel |
49 |
Effect of Quercetin on the Pharmacokinetics of Rosiglitazone, a CYP2C8 Substrate, in Healthy Subjects
|
Kim, Kyoung-Ah |
|
2005 |
|
8 |
p. 941-946 |
artikel |
50 |
Effect of Rosuvastatin on Warfarin Pharmacodynamics and Pharmacokinetics
|
Simonson, Steven G. |
|
2005 |
|
8 |
p. 927-934 |
artikel |
51 |
Effect of 393T>C Polymorphism of GNAS1 Gene on Dobutamine Response in Chinese Healthy Subjects
|
Mao, Yan-Mei |
|
2009 |
|
8 |
p. 929-936 |
artikel |
52 |
Effect of the Endothelin-Receptor Antagonist Bosentan on the Pharmacokinetics and Pharmacodynamics of Warfarin
|
Weber, Cornelia |
|
1999 |
|
8 |
p. 847-854 |
artikel |
53 |
Effect of the Proton Pump Inhibitor Esomeprazole on the Oral Absorption and Pharmacokinetics of Nilotinib
|
Yin, Ophelia Q. P. |
|
2010 |
|
8 |
p. 960-967 |
artikel |
54 |
Effect of the Proton Pump Inhibitor Omeprazole on the Pharmacokinetics of Extended-Release Formulations of Oxybutynin and Tolterodine
|
Dmochowski, Roger |
|
2005 |
|
8 |
p. 961-968 |
artikel |
55 |
Effects of Meloxicam on Platelet Function in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
|
Rinder, Henry M. |
|
2002 |
|
8 |
p. 881-886 |
artikel |
56 |
Effects of Nicotine on the Number and Activity of Circulating Endothelial Progenitor Cells
|
Wang, XingXiang |
|
2004 |
|
8 |
p. 881-889 |
artikel |
57 |
Efficacy and Tolerability of Lornoxicam versus Tramadol in Postoperative Pain
|
Staunstrup, Henrik |
|
1999 |
|
8 |
p. 834-841 |
artikel |
58 |
Efficacy and Tolerability of Nonprescription Ibuprofen versus Celecoxib for Dental Pain
|
Doyle, Geraldine |
|
2002 |
|
8 |
p. 912-919 |
artikel |
59 |
Errata
|
|
|
2007 |
|
8 |
p. 1061-1061 |
artikel |
60 |
Erratum
|
|
|
1999 |
|
8 |
p. 866-866 |
artikel |
61 |
Ethnic Differences in Pharmacokinetics in New Drug Applications and Approved Doses in Japan
|
Fukunaga, Satoshi |
|
2011 |
|
8 |
p. 1237-1240 |
artikel |
62 |
Evaluation of Pharmacokinetic Interactions Between Vildagliptin and Digoxin in Healthy Volunteers
|
He, Yan-Ling |
|
2007 |
|
8 |
p. 998-1004 |
artikel |
63 |
Evaluation of Safety and Pharmacokinetics of Sodium 2,2 Dimethylbutyrate, a Novel Short Chain Fatty Acid Derivative, in a Phase 1, Double-Blind, Placebo-Controlled, Single-Dose, and Repeat-Dose Studies in Healthy Volunteers
|
Perrine, Susan P. |
|
2011 |
|
8 |
p. 1186-1194 |
artikel |
64 |
Evaluation of the Potential for Pharmacodynamic and Pharmacokinetic Drug Interactions Between Selegiline Transdermal System and Two Sympathomimetic Agents (Pseudoephedrine and Phenylpropanolamine) in Healthy Volunteers
|
Azzaro, Albert J. |
|
2007 |
|
8 |
p. 978-990 |
artikel |
65 |
Exposure–Clinical Response Analysis of Paricalcitol in Patients With Chronic Kidney Disease (Stage 5) on Hemodialysis or Peritoneal Dialysis
|
Noertersheuser, Peter A. |
|
2012 |
|
8 |
p. 1162-1173 |
artikel |
66 |
Exposure-Dependent Inhibition of Intestinal and Hepatic CYP3A4 In Vivo by Grapefruit Juice
|
Veronese, Maria L. |
|
2003 |
|
8 |
p. 831-839 |
artikel |
67 |
Fangjiomics: In Search of Effective and Safe Combination Therapies
|
Wang, Zhong |
|
2011 |
|
8 |
p. 1132-1151 |
artikel |
68 |
FTY720: Placebo-Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects
|
Schmouder, Robert |
|
2006 |
|
8 |
p. 895-904 |
artikel |
69 |
Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans
|
Man, Michael |
|
2010 |
|
8 |
p. 929-940 |
artikel |
70 |
Highlightand Book Review: Danhof M, de Jongh J, De Lange ECM, Della Pasqua O, Ploeger B, Voskuyl RA. Mechanism-based pharmacokineticpharmacodynamic modeling: biophase, distribution, receptor theory, and dynamical systems analysis. Ann Rev Pharmacol Toxicol. 2007;47:357-400
|
|
|
2007 |
|
8 |
p. 1058-1058 |
artikel |
71 |
Highlightand Book Review: Harris RI, Steare SE. A meta-analysis of ECG data from healthy male volunteers: diurnal and intra-subject variability, and implications for planning ECG assessments and statistical analysis in clinical pharmacology studies. Eur J Clin Pharmacol. 2006;62;893-903
|
|
|
2007 |
|
8 |
p. 1055-1056 |
artikel |
72 |
Highlightand Book Review: Li JS, Eisenstein EL, Grabowski HG, et al. Economic return of clinical trials performed under the pediatric exclusivity program. JAMA. 2007;297:480-488
|
|
|
2007 |
|
8 |
p. 1056-1057 |
artikel |
73 |
Highlightand Book Review: Proost JH, Eleveld DJ. Performance of an iterative two-stage Bayesian technique for population pharmacokinetic analysis of rich data sets. Pharm Res. 2006;23:2748-2759
|
|
|
2007 |
|
8 |
p. 1057-1057 |
artikel |
74 |
Highlightand Book Review: Research Highlights
|
Bonate, Peter |
|
2007 |
|
8 |
p. 1055-1055 |
artikel |
75 |
Hospital Pharmacology: An Alternative Model for Practice and Training in Clinical Pharmacology
|
Lehmann, David F. |
|
2006 |
|
8 |
p. 850-854 |
artikel |
76 |
Impact of Target-Mediated Drug Disposition on Linagliptin Pharmacokinetics and DPP-4 Inhibition in Type 2 Diabetic Patients
|
Retlich, Silke |
|
2010 |
|
8 |
p. 873-885 |
artikel |
77 |
Improving the FDA’s Advisory Committee Process
|
Brass, Eric P. |
|
2012 |
|
8 |
p. 1277-1283 |
artikel |
78 |
Influence of Genetic Variants in UGT1A1 and UGT1A9 on the in Vivo Glucuronidation of SN-38
|
Paoluzzi, Luca |
|
2004 |
|
8 |
p. 854-860 |
artikel |
79 |
Influence of Glomerular Filtration Rate on the Pharmacokinetics of Cyclophosphamide Enantiomers in Patients With Lupus Nephritis
|
de Miranda Silva, Carolina |
|
2009 |
|
8 |
p. 965-972 |
artikel |
80 |
Interlaboratory Measurement Differences in Intracellular Carbovir Triphosphate Concentrations in HIV-Infected Patients: Sources of Variability in Processing, Shipping, and Quantitation
|
Goicoechea, Miguel |
|
2010 |
|
8 |
p. 968-974 |
artikel |
81 |
Intravenous Safety and Pharmacokinetics of a Novel Dimerizer Drug, AP1903, in Healthy Volunteers
|
Iuliucci, John D. |
|
2001 |
|
8 |
p. 870-879 |
artikel |
82 |
Irbesartan Does Not Affect the Pharmacokinetics of Simvastatin in Healthy Subjects
|
Marino, Maria R. |
|
2000 |
|
8 |
p. 875-879 |
artikel |
83 |
Ketoconazole and Rifampin Significantly Affect the Pharmacokinetics, But Not the Safety or QTc Interval, of Casopitant, a Neurokinin-1 Receptor Antagonist
|
Johnson, Brendan M. |
|
2010 |
|
8 |
p. 951-959 |
artikel |
84 |
Lack of Attenuation in the Antitumor Effect of Tamoxifen by Chronic CYP Isoform Inhibition
|
Lehmann, David |
|
2004 |
|
8 |
p. 861-865 |
artikel |
85 |
Lack of Effect of Aprepitant on Digoxin Pharmacokinetics in Healthy Subjects
|
Feuring, Martin |
|
2003 |
|
8 |
p. 912-917 |
artikel |
86 |
Long-Term Changes in Mycophenolic Acid Exposure in Combination with Tacrolimus and Corticosteroids are Dose Dependent and not Reflected by Trough Plasma Concentration: A Prospective Study in 100 De Novo Renal Allograft Recipients
|
Kuypers, D. R. J. |
|
2003 |
|
8 |
p. 866-880 |
artikel |
87 |
Lopinavir/Ritonavir Pharmacokinetic Profile: Impact of Sex and Other Covariates Following a Change From Twice-Daily to Once-Daily Therapy
|
Ofotokun, Ighovwerha |
|
2007 |
|
8 |
p. 970-977 |
artikel |
88 |
Lymphocyte Suppression by Rolipram with Other Immunosuppressive Drugs
|
Briggs, William A. |
|
1999 |
|
8 |
p. 794-799 |
artikel |
89 |
Measurement of Acetaminophen-Protein Adducts in Children and Adolescents with Acetaminophen Overdoses
|
James, Laura P. |
|
2001 |
|
8 |
p. 846-851 |
artikel |
90 |
Mechanism and Amelioration of Recombinant Human Interleukin-11 (rhIL-11)–Induced Anemia in Healthy Subjects
|
Dykstra, Kevin H. |
|
2000 |
|
8 |
p. 880-888 |
artikel |
91 |
Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid Arthritis
|
Wang, Bing |
|
2012 |
|
8 |
p. 1150-1161 |
artikel |
92 |
Mesna as a Nonvitamin Intervention to Lower Plasma Total Homocysteine Concentration: Implications for Assessment of the Homocysteine Theory of Atherosclerosis
|
Urquhart, Bradley L. |
|
2007 |
|
8 |
p. 991-997 |
artikel |
93 |
Minimal Interaction between Gatifloxacin and Oxycodone
|
Grant, Edward M. |
|
2002 |
|
8 |
p. 928-932 |
artikel |
94 |
Modeling of In Vitro Drug Activity and Prediction of Clinical Outcome in Acute Myeloid Leukemia
|
Quartino, Angelica |
|
2007 |
|
8 |
p. 1014-1021 |
artikel |
95 |
Montelukast Dose Selection in 6- to 14-Year-Olds: Comparison of Single-Dose Pharmacokinetics in Children and Adults
|
Knorr, Barbara |
|
1999 |
|
8 |
p. 786-793 |
artikel |
96 |
Moricizine Bioavailability via Simultaneous, Dual, Stable Isotope Administration: Bioequivalence Implications
|
Pieniaszek, Henry J. |
|
1999 |
|
8 |
p. 817-825 |
artikel |
97 |
Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis
|
Donnenberg, Vera S. |
|
2005 |
|
8 |
p. 872-877 |
artikel |
98 |
Mycophenolate Mofetil in Islet Cell Transplant: Variable Pharmacokinetics but Good Correlation Between Total and Unbound Concentrations
|
Jacobson, Pamala A. |
|
2005 |
|
8 |
p. 901-909 |
artikel |
99 |
Mycophenolic Acid Pharmacokinetics During Maintenance Immunosuppression in African American and Caucasian Renal Transplant Recipients
|
Tornatore, Kathleen M. |
|
2011 |
|
8 |
p. 1213-1222 |
artikel |
100 |
Naproxen 500 mg bid versus Acetaminophen 1000 mg qid: Effect on Swelling and Other Acute Postoperative Events after Bilateral Third Molar Surgery
|
Bjørnsson, G. A. |
|
2003 |
|
8 |
p. 849-858 |
artikel |
101 |
No Pharmacokinetic or Pharmacodynamic Interaction Between Atorvastatin and the Oral Direct Thrombin Inhibitor Ximelagatran
|
Sarich, Troy C. |
|
2004 |
|
8 |
p. 928-934 |
artikel |
102 |
No Pharmacokinetic or Pharmacodynamic Interaction Between Digoxin and the Oral Direct Thrombin Inhibitor Ximelagatran in Healthy Volunteers
|
Sarich, Troy C. |
|
2004 |
|
8 |
p. 935-941 |
artikel |
103 |
Omeprazole Disposition in Children following Single-Dose Administration
|
Kearns, Gregory L. |
|
2003 |
|
8 |
p. 840-848 |
artikel |
104 |
Omeprazole Impairs the Absorption of Mycophenolate Mofetil But Not of Enteric-Coated Mycophenolate Sodium in Healthy Volunteers
|
Kees, M. G. |
|
2012 |
|
8 |
p. 1265-1272 |
artikel |
105 |
Optimizing the Science of Drug Development: Opportunities for Better Candidate Selection and Accelerated Evaluation in Humans
|
Lesko, Lawrence J. |
|
2000 |
|
8 |
p. 803-814 |
artikel |
106 |
Oral Bioavailability and Disposition of [14C]Omapatrilat in Healthy Subjects
|
Malhotra, Bimal K. |
|
2001 |
|
8 |
p. 833-841 |
artikel |
107 |
Oritavancin, a New Lipoglycopeptide Antibiotic: Results From a Thorough QT Study
|
Darpo, Borje |
|
2010 |
|
8 |
p. 895-903 |
artikel |
108 |
Permeability and Concentration of Levofloxacin in Epithelial Lining Fluid in Patients With Lower Respiratory Tract Infections
|
Jing Zhang, |
|
2010 |
|
8 |
p. 922-928 |
artikel |
109 |
Pharmacokinetic and Pharmacodynamic Modeling of a Copper-Selective Chelator (TETA) in Healthy Adults
|
Cho, Hea-Young |
|
2009 |
|
8 |
p. 916-928 |
artikel |
110 |
Pharmacokinetic Interaction Between Efavirenz and Carbamazepine After Multiple-Dose Administration in Healthy Subjects
|
Ping Ji, |
|
2008 |
|
8 |
p. 948-956 |
artikel |
111 |
Pharmacokinetic Interaction Between Zolpidem and Carbamazepine in Healthy Volunteers
|
Vlase, Laurian |
|
2011 |
|
8 |
p. 1233-1236 |
artikel |
112 |
Pharmacokinetic Interactions of Concomitant Administration of Febuxostat and NSAIDs
|
Khosravan, Reza |
|
2006 |
|
8 |
p. 855-866 |
artikel |
113 |
Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP-4 Inhibitor Sitagliptin in Middle-Aged Obese Subjects
|
Herman, Gary A. |
|
2006 |
|
8 |
p. 876-886 |
artikel |
114 |
Pharmacokinetics and Pharmacodynamics of Warfarin When Coadministered With Pentosan Polysulfate Sodium
|
Modi, Nishit B. |
|
2005 |
|
8 |
p. 919-926 |
artikel |
115 |
Pharmacokinetics and Safety of Coadministered Oseltamivir and Rimantadine in Healthy Volunteers: An Open-Label, Multiple-Dose, Randomized, Crossover Study
|
Cirrincione-Dall, Georgina |
|
2012 |
|
8 |
p. 1255-1264 |
artikel |
116 |
Pharmacokinetics and Safety of FFR-rFVIIa after Single Doses in Healthy Subjects
|
Erhardtsen, Elisabeth |
|
2001 |
|
8 |
p. 880-885 |
artikel |
117 |
Pharmacokinetics and Safety of Marqibo (Vincristine Sulfate Liposomes Injection) in Cancer Patients With Impaired Liver Function
|
Bedikian, Agop Y. |
|
2011 |
|
8 |
p. 1205-1212 |
artikel |
118 |
Pharmacokinetics and Safety of the Lopinavir/Ritonavir Tablet 500/125 mg Twice Daily Coadministered With Efavirenz in Healthy Adult Participants
|
Ng, Juki |
|
2012 |
|
8 |
p. 1248-1254 |
artikel |
119 |
Pharmacokinetics, Bioequivalence, and Spray Weight Reproducibility of Intranasal Butorphanol After Administration With 2 Different Nasal Spray Pumps
|
Wermeling, Daniel P. |
|
2005 |
|
8 |
p. 969-973 |
artikel |
120 |
Pharmacokinetics, Efficacy, and Tolerability of Eslicarbazepine Acetate in Children and Adolescents With Epilepsy
|
Almeida, Luis |
|
2008 |
|
8 |
p. 966-977 |
artikel |
121 |
Pharmacokinetics of 852A, an Imidazoquinoline Toll-Like Receptor 7—Specific Agonist, Following Intravenous, Subcutaneous, and Oral Administrations in Humans
|
Harrison, Lester I. |
|
2007 |
|
8 |
p. 962-969 |
artikel |
122 |
Pharmacokinetics of Gemtuzumab Ozogamicin as a Single-Agent Treatment of Pediatric Patients with Refractory or Relapsed Acute Myeloid Leukemia
|
Buckwalter, Mary |
|
2004 |
|
8 |
p. 873-880 |
artikel |
123 |
Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers
|
Falcoz, Christine |
|
2002 |
|
8 |
p. 887-898 |
artikel |
124 |
Pharmacokinetics of High-Dose Abetimus Sodium in Normal Subjects With Specific Assessment of Effect on Coagulation
|
Linnik, Matthew D. |
|
2008 |
|
8 |
p. 909-918 |
artikel |
125 |
Pharmacokinetics of Ibuprofen Enantiomers in Children with Cystic Fibrosis
|
Dong, Jennifer Q. |
|
2000 |
|
8 |
p. 861-868 |
artikel |
126 |
Pharmacokinetics of M100240 and MDL 100,173, a Dual Angiotensin-Converting Enzyme/Neutral Endopeptidase Inhibitor, in Healthy Young and Elderly Volunteers
|
Emmons, Gary T. |
|
2004 |
|
8 |
p. 901-905 |
artikel |
127 |
Pharmacokinetics of Meloxicam in Patients with Juvenile Rheumatoid Arthritis
|
Burgos-Vargas, Rubén |
|
2004 |
|
8 |
p. 866-872 |
artikel |
128 |
Pharmacokinetics of O6-Benzylguanine (NSC637037) and its Metabolite, 8-Oxo-O6-Benzylguanine
|
Tserng, Kou-Yi |
|
2003 |
|
8 |
p. 881-893 |
artikel |
129 |
Pharmacokinetics of Ofloxacin Enantiomers after Intravenous Administration for Antibiotic Prophylaxis in Biliary Surgery
|
Gascón, A. R. |
|
2000 |
|
8 |
p. 869-874 |
artikel |
130 |
Pharmacokinetics, Safety, and Tolerability of Ascending Doses of Sublingual Fentanyl, With and Without Naltrexone, in Japanese Subjects
|
Lister, Nicola |
|
2011 |
|
8 |
p. 1195-1204 |
artikel |
131 |
Pharmacological and Clinical Profile of Moexipril: a Concise Review
|
Chrysant, Steven G. |
|
2004 |
|
8 |
p. 827-836 |
artikel |
132 |
Pharmacological Aspects and Potential New Clinical Applications of Ketamine: Reevaluation of an Old Drug
|
Aroni, Filippia |
|
2009 |
|
8 |
p. 957-964 |
artikel |
133 |
Pharmacological Risk Factors for Amphotericin B Nephrotoxicity in Children
|
Goldman, Ran D. |
|
2007 |
|
8 |
p. 1049-1054 |
artikel |
134 |
Pharmacology of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors (Statins), Including Rosuvastatin and Pitavastatin
|
Igel, Michael |
|
2002 |
|
8 |
p. 835-845 |
artikel |
135 |
Physiological, Pharmacokinetic, and Pharmacodynamic Changes in Space
|
Graebe, Annemarie |
|
2004 |
|
8 |
p. 837-853 |
artikel |
136 |
Population and Individual Bioequivalence: Lessons from Real Data and Simulation Studies
|
Zariffa, Névine M.-D. |
|
2001 |
|
8 |
p. 811-822 |
artikel |
137 |
Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON-TIMI 38
|
Wrishko, Rebecca E. |
|
2009 |
|
8 |
p. 984-998 |
artikel |
138 |
Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Aprotinin in Neonates and Young Infants Undergoing Cardiopulmonary Bypass
|
Tae, You-Me |
|
2011 |
|
8 |
p. 1163-1176 |
artikel |
139 |
Population Pharmacokinetic and Concentration–QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies
|
Florian, Jeffry A. |
|
2011 |
|
8 |
p. 1152-1162 |
artikel |
140 |
Population Pharmacokinetics of Amlodipine in Hypertensive Children and Adolescents
|
Flynn, Joseph T. |
|
2006 |
|
8 |
p. 905-916 |
artikel |
141 |
Population Pharmacokinetics of Liraglutide, a Once-Daily Human Glucagon-Like Peptide-1 Analog, in Healthy Volunteers and Subjects With Type 2 Diabetes, and Comparison to Twice-Daily Exenatide
|
Watson, Estelle |
|
2010 |
|
8 |
p. 886-894 |
artikel |
142 |
Population Pharmacokinetics of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder
|
Shader, Richard I. |
|
1999 |
|
8 |
p. 775-785 |
artikel |
143 |
Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid
|
Rayner, Craig R. |
|
2008 |
|
8 |
p. 935-947 |
artikel |
144 |
Population Pharmacokinetics of Pegaptanib in Patients With Neovascular, Age-Related Macular Degeneration
|
Basile, Anthony S. |
|
2012 |
|
8 |
p. 1186-1199 |
artikel |
145 |
Prediction of Prasugrel Active Metabolite Concentrations From 2 Downstream Inactive Metabolite Concentrations Using Multilinear Regression Analysis
|
Ernest, C. Steven |
|
2009 |
|
8 |
p. 973-983 |
artikel |
146 |
Probenecid, but Not Cystic Fibrosis, Alters the Total and Renal Clearance of Fexofenadine
|
Shanshan Liu, |
|
2008 |
|
8 |
p. 957-965 |
artikel |
147 |
Quantitative Clinical Pharmacology: Guidance for Authors and a Call for Papers
|
Krishna, Rajesh |
|
2008 |
|
8 |
p. 898-899 |
artikel |
148 |
Raloxifene, a New Selective Estrogen Receptor Modulator
|
Goldfrank, Deborah |
|
1999 |
|
8 |
p. 767-774 |
artikel |
149 |
Randomized 5-Treatment Crossover Study to Assess the Effects of External Heat on Serum Fentanyl Concentrations During Treatment With Transdermal Fentanyl Systems
|
Moore, Kenneth T. |
|
2012 |
|
8 |
p. 1174-1185 |
artikel |
150 |
Renal Interaction Between Itraconazole and Cimetidine
|
Karyekar, Chetan S. |
|
2004 |
|
8 |
p. 919-927 |
artikel |
151 |
Renal Safety and Pharmacokinetics of Ibandronate in Multiple Myeloma Patients With or Without Impaired Renal Function
|
Bergner, Raoul |
|
2007 |
|
8 |
p. 942-950 |
artikel |
152 |
Review: Potential Use of Erythromycin to Prevent and Treat Prosthetic Failure
|
Peng Zhang, |
|
2010 |
|
8 |
p. 858-860 |
artikel |
153 |
Risk Assessment in Regulatory Policy Making for Human and Veterinary Public Health
|
Lathers, Claire M. |
|
2002 |
|
8 |
p. 846-866 |
artikel |
154 |
Safety, Pharmacokinetics, and Pharmacodynamics of CHF 3381, a Novel N-Methyl-D-Aspartate Antagonist, after Single Oral Doses in Healthy Subjects
|
Tarral, Antoine |
|
2003 |
|
8 |
p. 901-911 |
artikel |
155 |
Safety, Tolerability, and Pharmacokinetic Profile of BIA 2-093, a Novel Putative Antiepileptic, in a Rising Multiple-Dose Study in Young Healthy Humans
|
Almeida, Luis |
|
2004 |
|
8 |
p. 906-918 |
artikel |
156 |
Safety, Tolerability, and Pharmacokinetics of KNS-760704 (Dexpramipexole) in Healthy Adult Subjects
|
Bozik, Michael E. |
|
2011 |
|
8 |
p. 1177-1185 |
artikel |
157 |
Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan
|
Malinowski, Henry J. |
|
2008 |
|
8 |
p. 900-908 |
artikel |
158 |
Scientific Considerations for Pharmacoenhancers in Antiretroviral Therapy
|
Arya, Vikram |
|
2012 |
|
8 |
p. 1128-1133 |
artikel |
159 |
Should Clinical Pharmacokinetic Bridging Studies Between Caucasian and Asian Populations Be Required for Approval of Monoclonal Antibodies?
|
Zhou, Honghui |
|
2012 |
|
8 |
p. 1273-1276 |
artikel |
160 |
Single- and Multiple-Dose Administration of Caspofungin in Patients With Hepatic Insufficiency: Implications for Safety and Dosing Recommendations
|
Mistry, Goutam C. |
|
2007 |
|
8 |
p. 951-961 |
artikel |
161 |
Single-Dose Pharmacokinetics of Roflumilast in Children and Adolescents
|
Neville, Kathleen A. |
|
2008 |
|
8 |
p. 978-985 |
artikel |
162 |
Single-Dose Pharmacokinetics of Valganciclovir in HIV- and CMV-Seropositive Subjects
|
Jung, Donald |
|
1999 |
|
8 |
p. 800-804 |
artikel |
163 |
Single-Dose Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Stimulator BAY 63-2521: An Ascending-Dose Study in Healthy Male Volunteers
|
Frey, Reiner |
|
2008 |
|
8 |
p. 926-934 |
artikel |
164 |
Steady-State Pharmacokinetics and Tolerability of Modafinil Given Alone or in Combination with Methylphenidate in Healthy Volunteers
|
Hellriegel, Edward T. |
|
2001 |
|
8 |
p. 895-904 |
artikel |
165 |
Steady-State Pharmacokinetics of Carvedilol and Its Enantiomers in Patients with Congestive Heart Failure
|
Tenero, David |
|
2000 |
|
8 |
p. 844-853 |
artikel |
166 |
Submitting Manuscripts to the Journal of Clinical Pharmacology
|
|
|
2005 |
|
8 |
p. 975-975 |
artikel |
167 |
Sudies on the Pharmacokinetics and Pharmacodynamics of Propranolol in Hyperlipidemia
|
Wójcicki, Jerzy |
|
1999 |
|
8 |
p. 826-833 |
artikel |
168 |
Systemic Absorption of Clindamycin after Intravaginal Administration of Clindamycin Phosphate Ovule or Cream
|
Borin, Marie T. |
|
1999 |
|
8 |
p. 805-810 |
artikel |
169 |
Systemic and Renal Pharmacokinetics of Adefovir and Tenofovir Upon Coadministration
|
Kearney, Brian P. |
|
2005 |
|
8 |
p. 935-940 |
artikel |
170 |
The Effect of Azithromycin on the Pharmacokinetics of Indinavir
|
Foulds, George |
|
1999 |
|
8 |
p. 842-846 |
artikel |
171 |
The Effect of Low-Dose Cimetidine (200 mg Twice Daily) on the Pharmacokinetics of Theophylline
|
Nix, David E. |
|
1999 |
|
8 |
p. 855-865 |
artikel |
172 |
The Effect of Oral Contraceptives on the Pharmacokinetics of Melatonin in Healthy Subjects With CYP1A2 g.-163C>A Polymorphism
|
Hilli, Johanna |
|
2008 |
|
8 |
p. 986-994 |
artikel |
173 |
The Effects of Multiple Doses of Fenofibrate on the Pharmacokinetics of Pravastatin and Its 3α-Hydroxy Isomeric Metabolite
|
Gustavson, Linda E. |
|
2005 |
|
8 |
p. 947-953 |
artikel |
174 |
The Future of Clinical Trials in Chronic Renal Disease: Outcome of an NIH/FDA/Physician Specialist Conference
|
Bakris, George L. |
|
2000 |
|
8 |
p. 815-825 |
artikel |
175 |
The In Silico Child: Using Simulation to Guide Pediatric Drug Development and Manage Pediatric Pharmacotherapy
|
Läer, Stephanie |
|
2009 |
|
8 |
p. 889-904 |
artikel |
176 |
The Mechanisms of the Inhibitory Effects of Nonsteroidal Anti-Inflammatory Drugs on Bone Healing: A Concise Review
|
Harder, Adam T. |
|
2003 |
|
8 |
p. 807-815 |
artikel |
177 |
The Oral, Once-Daily Phosphodiesterase 4 Inhibitor Roflumilast Lacks Relevant Pharmacokinetic Interactions With Inhaled Budesonide
|
Hermann, Robert |
|
2007 |
|
8 |
p. 1005-1013 |
artikel |
178 |
The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers
|
Massarella, Joseph W. |
|
2000 |
|
8 |
p. 836-843 |
artikel |
179 |
The Pharmacokinetics of Enoxaparin Do Not Correlate With Its Pharmacodynamic Effect in Patients Receiving Dialysis Therapies
|
Brophy, Donald F. |
|
2006 |
|
8 |
p. 887-894 |
artikel |
180 |
The Risk of Liver Damage Associated with Minocycline: A Comparative Study
|
Seaman, Helen E. |
|
2001 |
|
8 |
p. 852-860 |
artikel |
181 |
The Role of TNFα in Ulcerative Colitis
|
Sands, Bruce E. |
|
2007 |
|
8 |
p. 930-941 |
artikel |
182 |
The Safety of Higher Than Standard Dose of Doxylamine-Pyridoxine (Diclectin ®) for Nausea and Vomiting of Pregnancy
|
Atanackovic, Gordana |
|
2001 |
|
8 |
p. 842-845 |
artikel |
183 |
Transcutaneous Electrical Acupoint Stimulation Potentiates Analgesic Effect of Morphine
|
Yuan, Chun-Su |
|
2002 |
|
8 |
p. 899-903 |
artikel |
184 |
Tyramine Pressor Sensitivity During Treatment With the Selegiline Transdermal System 6 mg/24 h in Healthy Subjects
|
Azzaro, Albert J. |
|
2006 |
|
8 |
p. 933-944 |
artikel |
185 |
Urinary Excretion and Metabolism of Arbutin after Oral Administration of Arctostaphylos uvae ursi Extract as Film-Coated Tablets and Aqueous Solution in Healthy Humans
|
Schindler, Gernot |
|
2002 |
|
8 |
p. 920-927 |
artikel |
186 |
Using Multiple Drug Exposure Levels to Optimize Power in Pharmacogenetic Trials
|
Judson, Richard |
|
2003 |
|
8 |
p. 816-824 |
artikel |
187 |
Variable Absorption of Carbidopa Affects Both Peripheral and Central Levodopa Metabolism
|
Durso, R. |
|
2000 |
|
8 |
p. 854-860 |
artikel |
188 |
Who Needs Individual Bioequivalence Studies for Narrow Therapeutic Index Drugs? A Case for Warfarin
|
Yacobi, Avraham |
|
2000 |
|
8 |
p. 826-835 |
artikel |
189 |
Why Should Prediction Discrepancies Be Renamed Standardized Visual Predictive Check?
|
Comets, Emmanuelle |
|
2012 |
|
8 |
p. 1284-1285 |
artikel |